Louisiana Woman Claims Serzone Manufacturer Failed to Provide Adequate Warnings Concerning Liver Damage

NEW ORLEANS-Bristol-Myers Squibb Co., the manufacturer of Serzone, allegedly marketed and sold a defective product and failed to adequately warn consumers and physicians of the antidepressant's ability to cause liver failure and liver necrosis, a Louisiana woman claims. Bartlett v. Bristol-Myers Squibb Co., No. 02-2908 (E.D. La.).

Randi Bartlett's Sept. 20 complaint states that she was unaware of the dangers associated with the drug and allegedly suffered 'severe and debilitating' injuries as a result of ingesting Serzone to treat her depression. She also claims that her use of the antidepressant has put her at an increased risk of contracting severe …